How a 100-year-old study spawned a novel class of multifunctional neurological treatments.

Read the latest on Bloom Science’s epilepsy and ALS lead programs and how a 100-year-old study spawned a novel class of multifunctional neurological treatments via our Nature Biopharma Dealmakers article.